Dear Investor,

Please find attached a press release from our partner Sarepta Therapeutics:


https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-fda-approval-elevidys-first-gene

For further information please also have a look at the attached Roche statement on the accelerated approval of Elevidys™ granted by the FDA.

Do not hesitate to contact us for any further questions.

With best regards,

Attachment

• 230623_approval-dmd-delmox-fda-accelerated-approval-media-statement-final